Status:
COMPLETED
Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer
Lead Sponsor:
Cem Ilgin Erol
Conditions:
Breast Cancer
Chemotherapy Effect
Eligibility:
FEMALE
18+ years
Brief Summary
The current study aims to determine the diagnostic accuracy of Magnetic Resonance Imaging (MRI) and Positron Emission Tomography- Computed Tomography (PET-CT) in predicting a pathological response of ...
Detailed Description
Eighty-eight patients with breast cancer who had undergone surgery after NAC were retrospectively analyzed between January 2018 and May 2020, at the general surgery clinic of Istanbul Medeniyet Univer...
Eligibility Criteria
Inclusion
- Older than 18
- Breast cancer patients
- Had neoadjuvant chemotherapy before surgery
- Had undergone surgery after chemotherapy
Exclusion
- Younger than 18
- History of surgery for breast cancer
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT04882371
Start Date
January 1 2018
End Date
August 1 2020
Last Update
May 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medeniyet University Goztepe City Hospital
Istanbul, Kadikoy, Turkey (Türkiye), 34100